Name: Fusobacterium nucleatum 1612A
Creator: BacDive
License: https://creativecommons.org/licenses/by/4.0/

Strain identifier

BacDive ID: 5765

Type strain:

Species: Fusobacterium nucleatum

Strain Designation: 1612A

Culture col. no.: DSM 15643, ATCC 25586, CCUG 32989, CIP 101130, JCM 8532, LMG 13131, VPI 4355, BCRC 10681, CCUG 33059, KCTC 2640

Strain history: CIP <- 1984, ATCC <- W.E.C. Moore: strain VPI 4355 <- A.R. Prévot, Inst. Pasteur, Paris, France: strain 1612A

NCBI tax ID(s): 190304 (strain), 851 (species)

SI-ID 92417

LMG 13131, ATCC 25586, CCUG 32989, CCUG 33059, CIP 101130, JCM 8532, CCRC 10681, KCTC 2640, DSM 15643, BCRC 10681, KCTC 5103, ACM 3992

Special Collections

Other strains from Fusobacterium nucleatum

Section

Fusobacterium nucleatum 1612A is an anaerobe, Gram-negative bacterium that was isolated from cervico-facial lesion.

Gram-negative
anaerobe
16S sequence
Bacteria
genome sequence

Information on the name and the taxonomic classification. Name and taxonomic classification

	Last LPSN update	14-12-2023 (DD-MM-YYYY)
	Domain	"Bacteria"
	Phylum	*Fusobacteriota*
	Class	*Fusobacteriia*
	Order	*Fusobacteriales*
	Family	*Fusobacteriaceae*
	Genus	*Fusobacterium*
	Species	**Fusobacterium nucleatum**
	Full Scientific Name (LPSN)	Fusobacterium nucleatum Knorr 1922 (Approved Lists 1980)

Information on morphological and physiological properties Morphology

[Ref.: #121367]	Gram stain	negative

[Ref.: #121367]	Cell shape	rod-shaped

[Ref.: #121367]	Motility	no

[Ref.: #6013]

Incubation period

1-2 days

Information on culture and growth conditions Culture and growth conditions

[Ref.: #6013]

Culture medium

COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)

[Ref.: #6013]

Culture medium growth

[Ref.: #6013]

Culture medium link

Medium recipe at MediaDive

[Ref.: #6013]

Culture medium composition

expand / minimize

[Ref.: #6013]

Culture medium

PYG MEDIUM (MODIFIED) (DSMZ Medium 104)

[Ref.: #6013]

Culture medium growth

[Ref.: #6013]

Culture medium link

Medium recipe at MediaDive

[Ref.: #6013]

Culture medium composition

expand / minimize

[Ref.: #35308]

Culture medium

MEDIUM 20 - for Anaerobic bacteria

[Ref.: #35308]

Culture medium growth

[Ref.: #35308]

Culture medium composition

expand / minimize

[Ref.: #121367]

Culture medium

CIP Medium 45

[Ref.: #121367]

Culture medium growth

[Ref.: #121367]

Culture medium link

Medium recipe provided by DSMZ

[Ref.: #121367]

Culture medium

CIP Medium 20

[Ref.: #121367]

Culture medium growth

[Ref.: #121367]

Culture medium link

Medium recipe provided by DSMZ

		Temperature
[Ref.: #6013]	growth	37 °C
[Ref.: #35308]	growth	37 °C
[Ref.: #67770]	growth	37 °C

Information on physiology and metabolism Physiology and metabolism

[Ref.: #6013]	Oxygen tolerance	anaerobe
[Ref.: #121367]	Oxygen tolerance	anaerobe

	Metabolite	Utilization activity	Kind of utilization tested
[Ref.: #68371]	amygdalin ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	arbutin ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68380]	arginine ChEBI	-	hydrolysis	* from API rID32A
[Ref.: #121367]	cellobiose ChEBI	-	degradation
[Ref.: #68371]	cellobiose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #121367]	D-arabinose ChEBI	-	degradation
[Ref.: #68371]	D-arabinose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-arabitol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #121367]	D-fructose ChEBI	-	degradation
[Ref.: #68371]	D-fructose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-fucose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-galactose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #121367]	D-glucose ChEBI	-	degradation
[Ref.: #68371]	D-glucose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-lyxose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-mannitol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-mannose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68380]	D-mannose ChEBI	-	fermentation	* from API rID32A
[Ref.: #68371]	D-ribose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-sorbitol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	D-tagatose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #121367]	D-xylose ChEBI	-	degradation
[Ref.: #68371]	D-xylose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	erythritol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #121367]	esculin ChEBI	-	hydrolysis
[Ref.: #68371]	esculin ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	galactitol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	gentiobiose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	gluconate ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	glycerol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	glycogen ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	inulin ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	L-arabinose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	L-arabitol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	L-fucose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68380]	L-glutamate ChEBI	-	degradation	* from API rID32A
[Ref.: #68371]	L-rhamnose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	L-sorbose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	L-xylose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #121367]	lactose ChEBI	-	degradation
[Ref.: #68371]	lactose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #121367]	maltose ChEBI	-	degradation
[Ref.: #68371]	maltose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	melezitose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	melibiose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	methyl alpha-D-glucopyranoside ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	methyl alpha-D-mannoside ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	methyl beta-D-xylopyranoside ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	myo-inositol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	N-acetylglucosamine ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #121367]	nitrate ChEBI	-	reduction
[Ref.: #121367]	nitrate ChEBI	+	respiration
[Ref.: #121367]	nitrite ChEBI	-	reduction
[Ref.: #68371]	Potassium 2-ketogluconate ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	Potassium 5-ketogluconate ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	raffinose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68380]	raffinose ChEBI	-	fermentation	* from API rID32A
[Ref.: #68371]	ribitol ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #121367]	salicin ChEBI	-	degradation
[Ref.: #68371]	salicin ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	starch ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #121367]	sucrose ChEBI	-	degradation
[Ref.: #68371]	sucrose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	trehalose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68371]	turanose ChEBI	-	builds acid from	* from API 50CH acid
[Ref.: #68380]	urea ChEBI	-	hydrolysis	* from API rID32A
[Ref.: #68371]	xylitol ChEBI	-	builds acid from	* from API 50CH acid
	Only first 10 entries are displayed. Click here to see all.

	Metabolite production	Metabolite	Production
[Ref.: #121367]		indole ChEBI	yes

	Enzyme	Enzyme activity	EC number
[Ref.: #68382]	acid phosphatase	+	3.1.3.2	* from API zym
[Ref.: #68380]	alanine arylamidase	-	3.4.11.2	* from API rID32A
[Ref.: #121367]	alcohol dehydrogenase	-	1.1.1.1
[Ref.: #68382]	alkaline phosphatase	-	3.1.3.1	* from API zym, API rID32A
[Ref.: #68380]	alpha-arabinosidase	-	3.2.1.55	* from API rID32A
[Ref.: #68382]	alpha-chymotrypsin	-	3.4.21.1	* from API zym
[Ref.: #68382]	alpha-fucosidase	-	3.2.1.51	* from API zym, API rID32A
[Ref.: #68382]	alpha-galactosidase	-	3.2.1.22	* from API zym, API rID32A
[Ref.: #68382]	alpha-glucosidase	+	3.2.1.20	* from API zym
[Ref.: #68380]	alpha-glucosidase	-	3.2.1.20	* from API rID32A
[Ref.: #68382]	alpha-mannosidase	-	3.2.1.24	* from API zym
[Ref.: #121367]	amylase	-
[Ref.: #68380]	arginine dihydrolase	-	3.5.3.6	* from API rID32A
[Ref.: #121367]	beta-galactosidase	+	3.2.1.23
[Ref.: #68382]	beta-galactosidase	-	3.2.1.23	* from API zym, API rID32A
[Ref.: #68380]	beta-Galactosidase 6-phosphate	-		* from API rID32A
[Ref.: #68382]	beta-glucosidase	-	3.2.1.21	* from API zym, API rID32A
[Ref.: #68382]	beta-glucuronidase	-	3.2.1.31	* from API zym, API rID32A
[Ref.: #121367]	caseinase	-	3.4.21.50
[Ref.: #121367]	catalase	-	1.11.1.6
[Ref.: #68382]	cystine arylamidase	-	3.4.11.3	* from API zym
[Ref.: #121367]	DNase	-
[Ref.: #68382]	esterase (C 4)	+		* from API zym
[Ref.: #68382]	esterase lipase (C 8)	+		* from API zym
[Ref.: #121367]	gelatinase	-
[Ref.: #68380]	glutamate decarboxylase	-	4.1.1.15	* from API rID32A
[Ref.: #68380]	glutamyl-glutamate arylamidase	-		* from API rID32A
[Ref.: #68380]	glycin arylamidase	-		* from API rID32A
[Ref.: #68380]	histidine arylamidase	-		* from API rID32A
[Ref.: #68380]	L-arginine arylamidase	-		* from API rID32A
[Ref.: #121367]	lecithinase	+
[Ref.: #68382]	leucine arylamidase	+	3.4.11.1	* from API zym
[Ref.: #68380]	leucine arylamidase	-	3.4.11.1	* from API rID32A
[Ref.: #68380]	leucyl glycin arylamidase	-	3.4.11.1	* from API rID32A
[Ref.: #121367]	lipase	-
[Ref.: #68382]	lipase (C 14)	-		* from API zym
[Ref.: #121367]	lysine decarboxylase	-	4.1.1.18
[Ref.: #68382]	N-acetyl-beta-glucosaminidase	-	3.2.1.52	* from API zym, API rID32A
[Ref.: #68382]	naphthol-AS-BI-phosphohydrolase	+		* from API zym
[Ref.: #121367]	ornithine decarboxylase	-	4.1.1.17
[Ref.: #121367]	oxidase	-
[Ref.: #68380]	phenylalanine arylamidase	-		* from API rID32A
[Ref.: #68380]	proline-arylamidase	-	3.4.11.5	* from API rID32A
[Ref.: #121367]	protease	+
[Ref.: #68380]	pyrrolidonyl arylamidase	-	3.4.19.3	* from API rID32A
[Ref.: #68380]	serine arylamidase	-		* from API rID32A
[Ref.: #68382]	trypsin	-	3.4.21.4	* from API zym
[Ref.: #121367]	tween esterase	-
[Ref.: #68380]	tyrosine arylamidase	-		* from API rID32A
[Ref.: #121367]	urease	-	3.5.1.5
[Ref.: #68380]	urease	-	3.5.1.5	* from API rID32A
[Ref.: #68382]	valine arylamidase	-		* from API zym
	Only first 10 entries are displayed. Click here to see all.

Fatty acid profile

Metadata FA analysis

Reference

[Ref.: #65615]

Fatty acid	Percentage	ECL
C14:0	29.4	14
C16:0	19	16
C16:1 ω7c	8.1	15.819
C18:2 ω6,9c/C18:0 ANTE	8	17.724
C16:0 3OH	7.1	17.52
C17:1 ISO I/C16:0 DMA	6.7	16.481
C14:0 3OH/C16:1 ISO I	5.4	15.485
C18:1 ω9c	5.3	17.769
C13:0 3OH/C15:1 i I/H	2.4	14.469
C18:0	2	18
C18:1 ω7c /12t/9t	1.9	17.824
C16:0 aldehyde	1.7	14.949
C15:0	0.9	15
C16:1 ω7c DMA	0.8	16.288
C13:1 at 12-13	0.7	12.931
C12:0	0.7	12

API® 50CH acid:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	ControlQ	Acid from glycerolGLY	Acid from erythritolERY	Acid from D-arabinoseDARA	Acid from L-arabinoseLARA	Acid from D-riboseRIB	Acid from D-xyloseDXYL	Acid from L-xyloseLXYL	Acid from D-adonitolADO	Acid from methyl beta-D-xylopyranosideMDX	Acid from D-galactoseGAL	Acid from D-glucoseGLU	Acid from D-fructoseFRU	Acid from D-mannoseMNE	Acid from L-sorboseSBE	Acid from L-rhamnoseRHA	Acid from dulcitolDUL	Acid from inositolINO	Acid from D-mannitolMAN	Acid from D-sorbitolSOR	Acid from methyl alpha-D-mannopyranosideMDM	Acid from methyl alpha-D-glucopyranosideMDG	Acid from N-acetyl-glucosamineNAG	Acid from amygdalinAMY	Acid from arbutinARB	Acid from esculinESC	Acid from salicinSAL	Acid from cellobioseCEL	Acid from maltoseMAL	Acid from lactoseLAC	Acid from melibioseMEL	Acid from sucroseSAC	Acid from trehaloseTRE	Acid from inulinINU	Acid from melezitoseMLZ	Acid from raffinoseRAF	Acid from starchAMD	Acid from glycogenGLYG	Acid from xylitolXLT	Acid from gentiobioseGEN	Acid from turanoseTUR	Acid from D-lyxoseLYX	Acid from D-tagatoseTAG	Acid from D-fucoseDFUC	Acid from L-fucoseLFUC	Acid from D-arabitolDARL	Acid from L-arabitolLARL	Acid from gluconateGNT	Acid from 2-Ketogluconate2KG	Acid from 5-Ketogluconate5KG
[Ref.: #121367]	8724	not determinedn.d.	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

API® rID32A:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Urease/urea hydrolysisURE	Arginine dihydrolaseADH (Arg)	alpha-Galactosidasealpha GAL	beta-Galactosidasebeta GAL	beta-Galactosidase 6-phosphatebeta GP	alpha-Glucosidasealpha GLU	beta-Glucosidasebeta GLU	alpha-Arabinosidasealpha ARA	beta-Glucuronidasebeta GUR	beta-N-Acetyl-beta-glucosaminidasebeta NAG	Fermentation of D-mannoseMNE	Fermentation of raffinoseRAF	Glutamate decarboxylaseGDC	alpha-Fucosidasealpha FUC	Reduction of nitrateNIT	Indole productionIND	Alkaline phosphatasePAL	L-arginine arylamidaseArgA	Proline arylamidaseProA	Leucyl glycin arylamidaseLGA	Phenylalanine arylamidasePheA	Leucine arylamidaseLeuA	Pyrrolidonyl arylamidasePyrA	Tyrosine arylamidaseTyrA	Alanine arylamidaseAlaA	Glycin arylamidaseGlyA	Histidine arylamidaseHisA	Glutamyl-glutamate arylamidaseGGA	Serine arylamidaseSerA
[Ref.: #6013]	13387	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	-	-	-	-	-	-	-
[Ref.: #6013]	12175	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	-	-	-	-	-	-	-
[Ref.: #6013]	12176	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	-	-	-	-	-	-	-
[Ref.: #6013]	12177	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	-	-	-	-	-	-	-
[Ref.: #6013]	12178	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	-	-	-	-	-	-	-
[Ref.: #6013]	12977	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	-	-	-	-	-	-	-
[Ref.: #6013]	13034	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	-	-	-	-	-	-	-
[Ref.: #6013]	13211	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	-	-	-	-	-	-	-
[Ref.: #6013]	13274	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	-	-	-	-	-	-	-	-
[Ref.: #6013]	12174	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	+	-	-	-	-	-	-	-	-	-	-	-	-	-

API® zym:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Control	2-naphthyl phosphateAlkaline phosphatase	2-naphthyl butyrateEsterase (C 4)	2-naphtyl caprylateEsterase Lipase (C 8)	2-naphthyl myristateLipase (C 14)	L-leucyl-2-naphthylamideLeucine arylamidase	L-valyl-2-naphthylamideValine arylamidase	L-cystyl-2-naphthylamideCystine arylamidase	N-benzoyl-DL-arginine-2-naphthylamideTrypsin	N-glutaryl-phenylalanine-2-naphthylamidealpha- Chymotrypsin	2-naphthyl phosphateAcid phosphatase	Naphthol-AS-BI-phosphateNaphthol-AS-BI-phosphohydrolase	6-Br-2-naphthyl-alphaD-galactpyranosidealpha- Galactosidase	2-naphthyl-betaD-galactpyranosidebeta- Galactosidase	Naphthol-AS-BI-betaD-glucuronidebeta- Glucuronidase	2-naphthyl-alphaD-glucopyranosidealpha- Glucosidase	6-Br-2-naphthyl-betaD-glucopyranosidebeta- Glucosidase	1-naphthyl-N-acetyl-betaD-glucosaminideN-acetyl-beta- glucosaminidase	6-Br-2-naphthyl-alphaD-mannopyranosidealpha- Mannosidase	2-naphthyl-alphaL-fucopyranosidealpha- Fucosidase
[Ref.: #121367]	6698	-	-	+	+	-	+	-	-	-	-	+	+	-	-	-	+	-	-	-	-

Information on isolation source, the sampling and environmental conditions Isolation, sampling and environmental information

[Ref.: #6013]	Sample type/isolated from	cervico-facial lesion

[Ref.: #67770]	Sample type/isolated from	Cervico-facial lesion

[Ref.: #121367]	Sample type/isolated from	Human, Cervico-facial lesion
* marker position based on {}

Isolation sources categories

#Host Body-Site	#Oral cavity and airways	#Throat
#Host Body-Site	#Other	#Wound

What are isolation sources categories?

[Ref.: #69479]

Global distribution of 16S sequence GQ301038 (>99% sequence identity) for Fusobacterium nucleatum from Microbeatlas

Aquatic Samples	188
Soil Samples	15
Animal Samples	3393
Plant Samples	16
Total Samples	3612

Information on possible application of the strain and its possible interaction with e.g. potential hosts Safety information

[Ref.: #6013]	Biosafety level	2	Risk group (German classification) According to TRBA 466
[Ref.: #121367]	Biosafety level	1	Risk group (French classification)

Information on genomic background e.g. entries in nucleic sequence databass Sequence information

16S Sequence information:

Only first 5 entries are displayed. Click here to see all.

	Sequence accession description	Seq. accession number	Sequence length (bp)	Sequence database	Associated NCBI tax ID
[Ref.: #6013]	Fusobacterium nucleatum subsp. nucleatum ATCC 25586, complete genome	AE009951	11396	GenBank ENA	190304 tax ID
[Ref.: #20218]	Fusobacterium nucleatum subsp. nucleatum 16S ribosomal RNA gene	AJ133496	1479	GenBank ENA	190304 tax ID	*
[Ref.: #20218]	Fusobacterium nucleatum subsp. nucleatum strain ATCC 25586 16S ribosomal RNA gene, partial sequence; internal transcribed spacer 1, complete sequence; and 23S ribosomal RNA gene, partial sequence	AF342829	745	GenBank ENA	190304 tax ID	*
[Ref.: #20218]	Fusobacterium nucleatum subsp. nucleatum small subunit ribosomal RNA	X55401	1331	GenBank ENA	190304 tax ID	*
[Ref.: #20218]	Fusobacterium nucleatum subsp. nucleatum strain ATCC 25586 16S ribosomal RNA gene, partial sequence	GQ301038	1442	GenBank ENA	190304 tax ID	*
[Ref.: #20218]	Fusobacterium nucleatum subsp. nucleatum gene for 16S ribosomal RNA, partial sequence, strain: JCM 8532	AB573068	1481	GenBank ENA	190304 tax ID	*
[Ref.: #20218]	Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone C1_short_clone2 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequence	JQ724660	1023	GenBank ENA	190304 tax ID	*
[Ref.: #20218]	Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone C1_short_clone4 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequence	JQ724661	1023	GenBank ENA	190304 tax ID	*
[Ref.: #20218]	Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone C1_short_clone5 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequence	JQ724662	1023	GenBank ENA	190304 tax ID	*
[Ref.: #20218]	Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone A1_long_clone7 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequence	JQ724663	1199	GenBank ENA	190304 tax ID	*
[Ref.: #20218]	Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone C1_short_clone8 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequence	JQ724664	1023	GenBank ENA	190304 tax ID	*
[Ref.: #20218]	Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone C1_short_clone13 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequence	JQ724665	1023	GenBank ENA	190304 tax ID	*
[Ref.: #20218]	Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone C1_short_clone14 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequence	JQ724666	1022	GenBank ENA	190304 tax ID	*
[Ref.: #20218]	Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone C1_short_clone15 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequence	JQ724667	1023	GenBank ENA	190304 tax ID	*
[Ref.: #20218]	Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone A1_long_clone16 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequence	JQ724668	1200	GenBank ENA	190304 tax ID	*
[Ref.: #20218]	Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone C1_short_clone17 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequence	JQ724669	1023	GenBank ENA	190304 tax ID	*
[Ref.: #20218]	Fusobacterium nucleatum subsp. nucleatum small subunit ribosomal RNA gene sequence	M58683	1522	GenBank ENA	190304 tax ID	*

Genome sequence information:

	Sequence accession description	Seq. accession number	Assembly level	Sequence database	Associated NCBI tax ID
[Ref.: #66792]	Fusobacterium nucleatum subsp. nucleatum ATCC 25586	GCA_000007325	complete	GenBank ENA	190304 tax ID	*
[Ref.: #66792]	Fusobacterium nucleatum subsp. nucleatum ATCC 25586	190304.8	complete	PATRIC	190304 tax ID	*
[Ref.: #66792]	Fusobacterium nucleatum nucleatum ATCC 25586	637000117	complete	JGI IMG/M	190304 tax ID	*

Data predicted using genome information as a basis Genome-based predictions

	Trait	Model	Prediction	Confidence in %	In training data
	Predictions from GenomeNet Sporulation v. 1 based on: Fusobacterium nucleatum subsp. nucleatum ATCC 25586 PATRIC: 190304.8
[Ref.: #69481]	spore-forming	spore-formingⓘ	yes	80	no

	Trait	Model	Prediction	Confidence in %	In training data
	Predictions from Diaspora project based on: Fusobacterium nucleatum subsp. nucleatum ATCC 25586 ATCC 25586 NCBI: GCA_000007325.1
[Ref.: #69480]	gram-positive	gram-positiveⓘ	no	86.695	no
[Ref.: #69480]	anaerobic	anaerobicⓘ	yes	89.53	yes
[Ref.: #69480]	aerobic	aerobicⓘ	no	96.104	yes
[Ref.: #69480]	spore-forming	spore-formingⓘ	no	81.869	no
[Ref.: #69480]	thermophilic	thermophileⓘ	no	95.155	yes
[Ref.: #69480]	flagellated	motile2+ⓘ	no	84.5	no

Availability in culture collections External links

[Ref.: #6013]

Culture collection no.

DSM 15643, ATCC 25586, CCUG 32989, CIP 101130, JCM 8532, LMG 13131, VPI 4355, BCRC 10681, CCUG 33059, KCTC 2640

[Ref.: #75244]

SI-ID 92417

Literature:

Only first 10 entries are displayed. Click here to see all.

	Title	Authors	Journal	DOI	Year
Metabolism	Fusobacterium nucleatum Accelerates Atherosclerosis via Macrophage-Driven Aberrant Proinflammatory Response and Lipid Metabolism.	Zhou J, Liu L, Wu P, Zhao L, Wu Y	Front Microbiol	10.3389/fmicb.2022.798685	2022	*
Transcriptome	Transcriptome analysis of Fusobacterium nucleatum reveals differential gene expression patterns in the biofilm versus planktonic cells.	Zhao T, Chen J, Liu S, Yang J, Wu J, Miao L, Sun W	Biochem Biophys Res Commun	10.1016/j.bbrc.2021.11.075	2022	*
Pathogenicity	Disruption of Metallostasis in the Anaerobic Human Pathogen Fusobacterium nucleatum by the Zinc Ionophore PBT2.	Van Zuylen EM, Ferguson SA, Hughes A, Rennison D, Brimble MA, Cook GM	ACS Infect Dis	10.1021/acsinfecdis.0c00887	2021	*
Pathogenicity	New Pyrimidinone-Fused 1,4-Naphthoquinone Derivatives Inhibit the Growth of Drug Resistant Oral Bacteria.	Kim K, Kim D, Lee H, Lee TH, Kim KY, Kim H	Biomedicines	10.3390/biomedicines8060160	2020	*
Pathogenicity	Thymoquinone inhibits biofilm formation and virulence properties of periodontal bacteria.	Tantivitayakul P, Kaypetch R, Muadchiengka T	Arch Oral Biol	10.1016/j.archoralbio.2020.104744	2020	*
Metabolism	Protocol of proceedings with Fusobacterium nucleatum and optimization of ABTS method for detection of reactive oxygen species.	Kedziora A, Lesiow MK, Krupa K, Korzeniowska-Kowal A, Adamski R, Komarnicka UK, Stokowa-Soltys K, Bugla-Ploskonska G, Jezowska-Bojczuk M	Future Microbiol	10.2217/fmb-2019-0010	2020	*
Phylogeny	Utilizing Whole Fusobacterium Genomes To Identify, Correct, and Characterize Potential Virulence Protein Families.	Umana A, Sanders BE, Yoo CC, Casasanta MA, Udayasuryan B, Verbridge SS, Slade DJ	J Bacteriol	10.1128/JB.00273-19	2019	*
Genetics	Fusobacterium Genomics Using MinION and Illumina Sequencing Enables Genome Completion and Correction.	Todd SM, Settlage RE, Lahmers KK, Slade DJ	mSphere	10.1128/mSphere.00269-18	2018	*
Cultivation	Two mechanisms of oral malodor inhibition by zinc ions.	Suzuki N, Nakano Y, Watanabe T, Yoneda M, Hirofuji T, Hanioka T	J Appl Oral Sci	10.1590/1678-7757-2017-0161	2018	*
Metabolism	Structural insights into the catalytic mechanism of cysteine (hydroxyl) lyase from the hydrogen sulfide-producing oral pathogen, Fusobacterium nucleatum.	Kezuka Y, Ishida T, Yoshida Y, Nonaka T	Biochem J	10.1042/BCJ20170838	2018	*
Enzymology	A chemical and biological toolbox for Type Vd secretion: Characterization of the phospholipase A1 autotransporter FplA from Fusobacterium nucleatum.	Casasanta MA, Yoo CC, Smith HB, Duncan AJ, Cochrane K, Varano AC, Allen-Vercoe E, Slade DJ	J Biol Chem	10.1074/jbc.M117.819144	2017	*
Proteome	Mining the Proteome of Fusobacterium nucleatum subsp. nucleatum ATCC 25586 for Potential Therapeutics Discovery: An In Silico Approach.	Habib AM, Islam MS, Sohel M, Mazumder MH, Sikder MO, Shahik SM	Genomics Inform	10.5808/GI.2016.14.4.255	2016	*
Pathogenicity	Strain-Specific Impact of Fusobacterium nucleatum on Neutrophil Function.	Kurgan S, Kansal S, Nguyen D, Stephens D, Koroneos Y, Hasturk H, Van Dyke TE, Kantarci A	J Periodontol	10.1902/jop.2016.160212	2016	*
Phylogeny	Bacterial invasion into radicular dentine-an in vitro study.	Stauffacher S, Lussi A, Nietzsche S, Neuhaus KW, Eick S	Clin Oral Investig	10.1007/s00784-016-1960-7	2016	*
Metabolism	Discovery and characterization of de novo sialic acid biosynthesis in the phylum Fusobacterium.	Lewis AL, Robinson LS, Agarwal K, Lewis WG	Glycobiology	10.1093/glycob/cww068	2016	*
Enzymology	Copaifera reticulata oleoresin: Chemical characterization and antibacterial properties against oral pathogens.	Bardaji DK, da Silva JJ, Bianchi TC, de Souza Eugenio D, de Oliveira PF, Leandro LF, Rogez HL, Venezianni RC, Ambrosio SR, Tavares DC, Bastos JK, Martins CH	Anaerobe	10.1016/j.anaerobe.2016.04.017	2016	*
Metabolism	FAD-I, a Fusobacterium nucleatum Cell Wall-Associated Diacylated Lipoprotein That Mediates Human Beta Defensin 2 Induction through Toll-Like Receptor-1/2 (TLR-1/2) and TLR-2/6.	Bhattacharyya S, Ghosh SK, Shokeen B, Eapan B, Lux R, Kiselar J, Nithianantham S, Young A, Pandiyan P, McCormick TS, Weinberg A	Infect Immun	10.1128/IAI.01311-15	2016	*
Pathogenicity	Morphological and functional adaptations of Fusobacterium nucleatum exposed to human neutrophil Peptide-1.	Musrati AA, Fteita D, Paranko J, Kononen E, Gursoy UK	Anaerobe	10.1016/j.anaerobe.2016.02.008	2016	*
Biotechnology	The Effect of Bamboo Leaf Extract Solution and Sodium Copper Chlorophyllin Solution on Growth and Volatile Sulfur Compounds Production of Oral Malodor Associated Some Anaerobic Periodontal Bacteria.	Majbauddin A, Kodani I, Ryoke K	Yonago Acta Med		2015	*
Pathogenicity	Identification of an antibacterial protein by functional screening of a human oral metagenomic library.	Arivaradarajan P, Warburton PJ, Paramasamy G, Nair SP, Allan E, Mullany P	FEMS Microbiol Lett	10.1093/femsle/fnv142	2015	*
Pathogenicity	Essential oils and isolated compounds from Lippia alba leaves and flowers: antimicrobial activity and osteoclast apoptosis.	Juiz PJ, Lucchese AM, Gambari R, Piva R, Penolazzi L, Di Ciano M, Uetanabaro AP, Silva F, Avila-Campos MJ	Int J Mol Med	10.3892/ijmm.2014.1995	2014	*
Pathogenicity	Identification and characterization of fusolisin, the Fusobacterium nucleatum autotransporter serine protease.	Doron L, Coppenhagen-Glazer S, Ibrahim Y, Eini A, Naor R, Rosen G, Bachrach G	PLoS One	10.1371/journal.pone.0111329	2014	*
Pathogenicity	Increased proliferation and decreased membrane permeability as defense mechanisms of Fusobacterium nucleatum against human neutrophilic peptide-1.	Keskin M, Kononen E, Soderling E, Isik G, Firatli E, Uitto VJ, Gursoy UK	Anaerobe	10.1016/j.anaerobe.2014.08.001	2014	*
Metabolism	Biomechanical loading modulates proinflammatory and bone resorptive mediators in bacterial-stimulated PDL cells.	Nogueira AV, Nokhbehsaim M, Eick S, Bourauel C, Jager A, Jepsen S, Rossa C Jr, Deschner J, Cirelli JA	Mediators Inflamm	10.1155/2014/425421	2014	*
Pathogenicity	In vitro activity of Carvacrol against titanium-adherent oral biofilms and planktonic cultures.	Ciandrini E, Campana R, Federici S, Manti A, Battistelli M, Falcieri E, Papa S, Baffone W	Clin Oral Investig	10.1007/s00784-013-1179-9	2014	*
Pathogenicity	Regulation of visfatin by microbial and biomechanical signals in PDL cells.	Nogueira AV, Nokhbehsaim M, Eick S, Bourauel C, Jager A, Jepsen S, Cirelli JA, Deschner J	Clin Oral Investig	10.1007/s00784-013-0935-1	2013	*
Pathogenicity	Morphological, biochemical, physiological and molecular aspects of the response of Fusobacterium nucleatum exposed to subinhibitory concentrations of antimicrobials.	de Souza Filho JA, Diniz CG, Barbosa NB, de Freitas MC, Lopes Neves MS, da Gama Mazzei RN, Gameiro J, Coelho CM, da Silva VL	Anaerobe	10.1016/j.anaerobe.2012.09.007	2012	*
Phylogeny	Fretibacterium fastidiosum gen. nov., sp. nov., isolated from the human oral cavity.	Vartoukian SR, Downes J, Palmer RM, Wade WG	Int J Syst Evol Microbiol	10.1099/ijs.0.041038-0	2012	*
Pathogenicity	Human neutrophil defensins and their effect on epithelial cells.	Gursoy UK, Kononen E, Luukkonen N, Uitto VJ	J Periodontol	10.1902/jop.2012.120017	2012	*
Pathogenicity	Synergy in biofilm formation between Fusobacterium nucleatum and Prevotella species.	Okuda T, Kokubu E, Kawana T, Saito A, Okuda K, Ishihara K	Anaerobe	10.1016/j.anaerobe.2011.09.003	2011	*
Metabolism	Identification of an L-methionine gamma-lyase involved in the production of hydrogen sulfide from L-cysteine in Fusobacterium nucleatum subsp. nucleatum ATCC 25586.	Suwabe K, Yoshida Y, Nagano K, Yoshimura F	Microbiology (Reading)	10.1099/mic.0.051813-0	2011	*
Pathogenicity	A novel organotypic dento-epithelial culture model: effect of Fusobacterium nucleatum biofilm on B-defensin-2, -3, and LL-37 expression.	Gursoy UK, Pollanen M, Kononen E, Uitto VJ	J Periodontol	10.1902/jop.2011.110177	2011	*
Metabolism	Identification and enzymic analysis of a novel protein associated with production of hydrogen sulfide and L-serine from L-cysteine in Fusobacterium nucleatum subsp. nucleatum ATCC 25586.	Yoshida Y, Suwabe K, Nagano K, Kezuka Y, Kato H, Yoshimura F	Microbiology (Reading)	10.1099/mic.0.048934-0	2011	*
Metabolism	Myrsinoic acid B inhibits the production of hydrogen sulfide by periodontal pathogens in vitro.	Ito S, Shimura S, Tanaka T, Yaegaki K	J Breath Res	10.1088/1752-7155/4/2/026005	2010	*
Pathogenicity	Antimicrobial activity of sodium citrate against Streptococcus pneumoniae and several oral bacteria.	Nagaoka S, Murata S, Kimura K, Mori T, Hojo K	Lett Appl Microbiol	10.1111/j.1472-765X.2010.02932.x	2010	*
Metabolism	Fusobacterium nucleatum-associated beta-defensin inducer (FAD-I): identification, isolation, and functional evaluation.	Gupta S, Ghosh SK, Scott ME, Bainbridge B, Jiang B, Lamont RJ, McCormick TS, Weinberg A	J Biol Chem	10.1074/jbc.M110.133140	2010	*
Metabolism	Production of indole from L-tryptophan and effects of these compounds on biofilm formation by Fusobacterium nucleatum ATCC 25586.	Sasaki-Imamura T, Yano A, Yoshida Y	Appl Environ Microbiol	10.1128/AEM.00166-10	2010	*
Metabolism	Production of hydrogen sulfide by two enzymes associated with biosynthesis of homocysteine and lanthionine in Fusobacterium nucleatum subsp. nucleatum ATCC 25586.	Yoshida Y, Ito S, Kamo M, Kezuka Y, Tamura H, Kunimatsu K, Kato H	Microbiology (Reading)	10.1099/mic.0.039180-0	2010	*
Pathogenicity	Mixture of periodontopathogenic bacteria influences interaction with KB cells.	Kirschbaum M, Schultze-Mosgau S, Pfister W, Eick S	Anaerobe	10.1016/j.anaerobe.2010.03.009	2010	*
Pathogenicity	Biofilm formation enhances the oxygen tolerance and invasiveness of Fusobacterium nucleatum in an oral mucosa culture model.	Gursoy UK, Pollanen M, Kononen E, Uitto VJ	J Periodontol	10.1902/jop.2010.090664	2010	*
Metabolism	Stimulation of epithelial cell matrix metalloproteinase (MMP-2, -9, -13) and interleukin-8 secretion by fusobacteria.	Gursoy UK, Kononen E, Uitto VJ	Oral Microbiol Immunol	10.1111/j.1399-302X.2008.00453.x	2008	*
Pathogenicity	Interactions between salivary Bifidobacterium adolescentis and other oral bacteria: in vitro coaggregation and coadhesion assays.	Nagaoka S, Hojo K, Murata S, Mori T, Ohshima T, Maeda N	FEMS Microbiol Lett	10.1111/j.1574-6968.2008.01092.x	2008	*
Enzymology	Physiological alterations of a Fusobacterium nucleatum strain exposed to oxidative stress.	da Silva VL, Diniz CG, dos Santos SG, Gomes RM, Nicoli JR, Magalhaes PP, Mendes EN, de Carvalho MA, Farias LM	J Appl Microbiol	10.1111/j.1365-2672.2006.03236.x	2007	*
Metabolism	Effects of sonicated Prevotella intermedia, Fusobacterium nucleatum and Lactobacillus casei extracts on interleukin-8 production by human dental pulp cells.	Thaweboon B, Thaweboon S, Choonharuangdej S, Suppakpatana P	Southeast Asian J Trop Med Public Health		2006	*
Metabolism	Antimicrobial actions of benzimidazoles against the oral anaerobes Fusobacterium nucleatum and Prevotella intermedia.	Sheng J, Nguyen PT, Baldeck JD, Olsson J, Marquis RE	Arch Oral Biol	10.1016/j.archoralbio.2006.05.002	2006	*
Pathogenicity	Antimicrobial effect in vitro of chlorhexidine and calcium hydroxide impregnated gutta-percha points.	Bozza FL, Molgatini SL, Perez SB, Tejerina DP, Perez Tito RI, Kaplan AE	Acta Odontol Latinoam		2005	*
Phylogeny	Development of strain-specific PCR primers based on a DNA probe Fu12 for the identification of fusobacterium nucleatum subsp. nucleatum ATCC 25586T.	Kim HS, Song SK, Yoo SY, Jin DC, Shin HS, Lim CK, Kim MS, Kim JS, Choe SJ, Kook JK	J Microbiol	2257	2005	*
Pathogenicity	Enhanced pathogenicity of Fusobacterium nucleatum adapted to oxidative stress.	Silva VL, Diniz CG, Cara DC, Santos SG, Nicoli JR, Carvalho MA, Farias LM	Microb Pathog	10.1016/j.micpath.2005.07.002	2005	*
Metabolism	Identification and characterization of a novel adhesin unique to oral fusobacteria.	Han YW, Ikegami A, Rajanna C, Kawsar HI, Zhou Y, Li M, Sojar HT, Genco RJ, Kuramitsu HK, Deng CX	J Bacteriol	10.1128/JB.187.15.5330-5340.2005	2005	*
Metabolism	Protein secretion systems in Fusobacterium nucleatum: genomic identification of Type 4 piliation and complete Type V pathways brings new insight into mechanisms of pathogenesis.	Desvaux M, Khan A, Beatson SA, Scott-Tucker A, Henderson IR	Biochim Biophys Acta	10.1016/j.bbamem.2005.05.002	2005	*
Metabolism	Genome analysis of F. nucleatum sub spp vincentii and its comparison with the genome of F. nucleatum ATCC 25586.	Kapatral V, Ivanova N, Anderson I, Reznik G, Bhattacharyya A, Gardner WL, Mikhailova N, Lapidus A, Larsen N, D'Souza M, Walunas T, Haselkorn R, Overbeek R, Kyrpides N	Genome Res	10.1101/gr.566003	2003	*
Pathogenicity	Serum antibodies of periodontitis patients compared to the lipopolysaccharides of Porphyromonas gingivalis and Fusobacterium nucleatum.	Onoue S, Imai T, Kumada H, Umemoto T, Kaca W, Isshiki Y, Kaneko A, Kawahara K	Microbiol Immunol	10.1111/j.1348-0421.2003.tb02785.x	2003	*
Pathogenicity	In vitro effect of laser irradiation on cementum-bound endotoxin isolated from periodontally diseased roots.	Liu CM, Shyu YC, Pei SC, Lan WH, Hou LT	J Periodontol	10.1902/jop.2002.73.11.1260	2002	*
Pathogenicity	Activity of endodontic antibacterial agents against selected anaerobic bacteria.	Ferreira CM, da Silva Rosa OP, Torres SA, Ferreira FB, Bernardinelli N	Braz Dent J	10.1590/s0103-64402002000200008	2002	*
Pathogenicity	Effect of Fusobacterium nucleatum on the T and B cell responses to Porphyromonas gingivalis in a mouse model.	Gemmell E, Bird PS, Carter CL, Drysdale KE, Seymour GJ	Clin Exp Immunol	10.1046/j.1365-2249.2002.01852.x	2002	*
Pathogenicity	In vitro effect of intracanal medicaments on strict anaerobes by means of the broth dilution method.	Rosa OP, Torres SA, Ferreira CM, Ferreira FB	Pesqui Odontol Bras	10.1590/s1517-74912002000100006	2002	*
Metabolism	Genome sequence and analysis of the oral bacterium Fusobacterium nucleatum strain ATCC 25586.	Kapatral V, Anderson I, Ivanova N, Reznik G, Los T, Lykidis A, Bhattacharyya A, Bartman A, Gardner W, Grechkin G, Zhu L, Vasieva O, Chu L, Kogan Y, Chaga O, Goltsman E, Bernal A, Larsen N, D'Souza M, Walunas T, Pusch G, Haselkorn R, Fonstein M, Kyrpides N, Overbeek R	J Bacteriol	10.1128/JB.184.7.2005-2018.2002	2002	*
Pathogenicity	Kinetics of coaggregation of Porphyromonas gingivalis with Fusobacterium nucleatum using an automated microtiter plate assay.	Metzger Z, Featherstone LG, Ambrose WW, Trope M, Arnold RR	Oral Microbiol Immunol	10.1034/j.1399-302x.2001.016003163.x	2001	*
Pathogenicity	Abscess forming ability of streptococcus milleri group: synergistic effect with Fusobacterium nucleatum.	Nagashima H, Takao A, Maeda N	Microbiol Immunol	10.1111/j.1348-0421.1999.tb02395.x	1999	*
Pathogenicity	[A comparative in-vitro study of the bactericidal efficacy of sodium hypochlorite and chlorhexidine gluconate plus cetrimide on root canal anaerobic bacterial flora].	D'Arcangelo C, Varvara G	Minerva Stomatol		1998	*
Enzymology	Arbitrarily primed polymerase chain reaction fingerprinting and clonal analysis of oral Fusobacterium nucleatum isolates.	George KS, Reynolds MA, Falkler WA Jr	Oral Microbiol Immunol	10.1111/j.1399-302x.1997.tb00382.x	1997	*
Pathogenicity	Extraction and characterization of the smooth-type lipopolysaccharide from Fusobacterium nucleatum JCM 8532 and its biological activities.	Onoue S, Niwa M, Isshiki Y, Kawahara K	Microbiol Immunol	10.1111/j.1348-0421.1996.tb01075.x	1996	*
Enzymology	The Fusobacterium nucleatum major outer-membrane protein (FomA) forms trimeric, water-filled channels in lipid bilayer membranes.	Kleivdal H, Benz R, Jensen HB	Eur J Biochem	10.1111/j.1432-1033.1995.310_1.x	1995	*
Pathogenicity	Effect of periodontal treatments on serum IgG antibody titers against periodontopathic bacteria.	Horibe M, Watanabe H, Ishikawa I	J Clin Periodontol	10.1111/j.1600-051x.1995.tb00798.x	1995	*
Enzymology	Sizing the Fusobacterium nucleatum genome by pulsed-field gel electrophoresis.	Bolstad AI	FEMS Microbiol Lett	10.1111/j.1574-6968.1994.tb07214.x	1994	*
Genetics	Sequence variability of the 40-kDa outer membrane proteins of Fusobacterium nucleatum strains and a model for the topology of the proteins.	Bolstad AI, Tommassen J, Jensen HB	Mol Gen Genet	10.1007/BF00280193	1994	*
Metabolism	Methylation of adenine and cytosine in some strains of Fusobacterium nucleatum.	Bolstad AI, Jensen HB	Microb Pathog	10.1006/mpat.1993.1012	1993	*
Cultivation	Growth conditions and outer membrane proteins of Fusobacterium nucleatum.	Bakken V, Hogh BT, Jensen HB	Scand J Dent Res	10.1111/j.1600-0722.1990.tb00964.x	1990	*
Metabolism	Diisopropylfluorophosphate-binding proteins in the outer membrane of Fusobacterium nucleatum: strain variations.	Brokstad KA, Bakken V, Vasstrand EN, Jensen HB	FEMS Microbiol Lett	10.1016/0378-1097(90)90289-3	1990	*
Phylogeny	Proposal of three subspecies of Fusobacterium nucleatum Knorr 1922: Fusobacterium nucleatum subsp. nucleatum subsp. nov., comb. nov.; Fusobacterium nucleatum subsp. polymorphum subsp. nov., nom. rev., comb. nov.; and Fusobacterium nucleatum subsp. vincentii subsp. nov., nom. rev., comb. nov.	Dzink JL, Sheenan MT, Socransky SS	Int J Syst Bacteriol	10.1099/00207713-40-1-74	1990	*
Enzymology	Purification and partial characterization of a major outer-membrane protein of Fusobacterium nucleatum.	Bakken V, Aaro S, Jensen HB	J Gen Microbiol	10.1099/00221287-135-12-3253	1989	*
Enzymology	Structural analysis of lipopolysaccharides from Eikenella corrodens by use of murine monoclonal antibodies.	Kato T, Takazoe I, Okuda K	Infect Immun	10.1128/iai.57.2.656-659.1989	1989	*
Phylogeny	Production of monoclonal antibodies that recognize specific and cross-reactive antigens of Fusobacterium nucleatum.	Bird PS, Seymour GJ	Infect Immun	10.1128/iai.55.3.771-777.1987	1987	*
Phylogeny	Immunoglobulin G response to subgingival gram-negative bacteria in human subjects.	Naito Y, Okuda K, Takazoe I	Infect Immun	10.1128/iai.45.1.47-51.1984	1984	*
Metabolism	Pathway of lysine degradation in Fusobacterium nucleatum.	Barker HA, Kahn JM, Hedrick L	J Bacteriol	10.1128/jb.152.1.201-207.1982	1982	*
	Chalcones with potential antibacterial and antibiofilm activities against periodontopathogenic bacteria.	Satokata AAC, Souza JH, Silva LLO, Santiago MB, Ramos SB, Assis LR, Theodoro RDS, Oliveira LRE, Regasini LO, Martins CHG	Anaerobe	10.1016/j.anaerobe.2022.102588	2022	*
	A murine periodontitis model using coaggregation between human pathogens and a predominant mouse oral commensal bacterium.	Liu M, Choi Y	J Periodontal Implant Sci	10.5051/jpis.2104360218	2022	*
	Comparative evaluation of apical bacterial extrusion following root canal instrumentation using different endodontic file systems: An in vitro study.	Vankayala B, Anantula K, Saladi H, Gudugunta L, Basavarajaiah JM, Yadav SS	J Conserv Dent	10.4103/JCD.JCD_221_19	2020	*
	Pleural fluid penetration of moxifloxacin and doripenem: An experimental model of empyema.	Calik M, Calik SG, Dagli M, Kesli R, Esme H	North Clin Istanb	10.14744/nci.2019.05902	2019	*
	Antimicrobial Activity of Piper marginatum Jacq and Ilex guayusa Loes on Microorganisms Associated with Periodontal Disease.	Gamboa F, Munoz CC, Numpaque G, Sequeda-Castaneda LG, Gutierrez SJ, Tellez N	Int J Microbiol	10.1155/2018/4147383	2018	*
	A dual-species microbial model for studying the dynamics between oral streptococci and periodontal pathogens during biofilm development on titanium surfaces by flow cytometry.	Manti A, Ciandrini E, Campana R, Dominici S, Ciacci C, Federici S, Sisti D, Rocchi MB, Papa S, Baffone W	Res Microbiol	10.1016/j.resmic.2016.03.004	2016	*
	Antibacterial Activity of Myristica fragrans against Oral Pathogens.	Shafiei Z, Shuhairi NN, Md Fazly Shah Yap N, Harry Sibungkil CA, Latip J	Evid Based Complement Alternat Med	10.1155/2012/825362	2012	*
	In Vitro Antibacterial Activity of Galls of Quercus infectoria Olivier against Oral Pathogens.	Basri DF, Tan LS, Shafiei Z, Zin NM	Evid Based Complement Alternat Med	10.1155/2012/632796	2011	*
	Induction of systemic murine B-cell responses by Fusobacterium nucleatum and Porphyromonas gingivalis.	Nunes IP, Jonsson R, Jensen HB, Bakken V	Oral Microbiol Immunol	10.1111/j.1399-302x.1996.tb00349.x	1996	*

References

#6013

Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 15643

#20215

Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 )

#20218

Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.: StrainInfo introduces electronic passports for microorganisms.. Syst Appl Microbiol. 37: 42 - 50 2014 ( DOI 10.1016/j.syapm.2013.11.002 , PubMed 24321274 )

#35308 ; Curators of the CIP;
#65615 Culture Collection University of Gothenburg (CCUG) ; Curators of the CCUG; CCUG 32989

#66792

Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .

#67770 Japan Collection of Microorganism (JCM) ; Curators of the JCM;

#68371

Automatically annotated from API 50CH acid .

#68380

Automatically annotated from API rID32A .

#68382

Automatically annotated from API zym .

#69479

João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.: MicrobeAtlas 1.0 beta .

#69480

Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Predictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .

#69481

Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch: Predictions based on the model GenomeNet Sporulation v. 1 . ( DOI 10.21203/rs.3.rs-2527258/v1 )

#75244

Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.: StrainInfo: A central database for resolving microbial strain identifiers . ( DOI 10.60712/SI-ID92417.1 )

#121367 Collection of Institut Pasteur ; Curators of the CIP; CIP 101130
* These data were automatically processed and therefore are not curated

Change proposal

You found an error in BacDive? Please tell us about it!

Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.

Search for species Fusobacterium nucleatum subsp. nucleatum in external resources:
SILVA
BRENDA
PANGAEA
GBIF

Fusobacterium nucleatum subsp. nucleatum ATCC 25586

Fusobacterium nucleatum subsp. nucleatum ATCC 25586 ATCC 25586

Change proposal

Change proposal